Feijian Zeng , Yao Liang , Yufei Wei , Yonghua Huang , Yan Yan , Yongjun Wu , Guihua Huang
{"title":"Chrysophanol inhibits ischemia/reperfusion-induced neuronal pyroptosis by regulating NRF2/ARE/GSDMD signaling pathway","authors":"Feijian Zeng , Yao Liang , Yufei Wei , Yonghua Huang , Yan Yan , Yongjun Wu , Guihua Huang","doi":"10.1016/j.tice.2025.103082","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Chrysophanol (CHR) has been shown to afford significant neuroprotection on ischemic stroke (IS). This study aimed to investigate the effects of CHR on cerebral ischemia/reperfusion (I/R).</div></div><div><h3>Methods</h3><div>MCAO/R was used to establish mouse IS model. Histological analysis was performed using Nissl staining. Neuronal loss was detected using TUNEL staining. OGD/R was used to establish <em>in vitro</em> cerebral I/R injury model. Gene expression was detected using RT-qPCR and Western blot. Cytokine release was detected using ELISA. Cellular functions were detected using CCK-8 assay, LDH assay, flow cytometry, and TUNEL staining. GSDMD transcription was detected using luciferase and ChIP assays.</div></div><div><h3>Results</h3><div>CHR alleviated OGD/R induced neuronal damage, as well as inhibited oxidative stress, inflammatory response, and neuronal pyroptosis <em>in vivo</em> and <em>in vitro</em>. CHR promoted the activation of NRF2/ARE signaling. NRF2 inhibited the transcription of GSDMD, resulting in its downregulation. However, inhibition of NRF2 signaling contributed to neuronal damage and pyroptosis.</div></div><div><h3>Conclusions</h3><div>CHR protects against cerebral I/R injury-induced neuronal loss by regulating NRF2/ARE/GSDMD signaling pathway. Therefore, CHR may be a promising strategy for cerebral I/R injury.</div></div>","PeriodicalId":23201,"journal":{"name":"Tissue & cell","volume":"97 ","pages":"Article 103082"},"PeriodicalIF":2.5000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Tissue & cell","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0040816625003623","RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ANATOMY & MORPHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Chrysophanol (CHR) has been shown to afford significant neuroprotection on ischemic stroke (IS). This study aimed to investigate the effects of CHR on cerebral ischemia/reperfusion (I/R).
Methods
MCAO/R was used to establish mouse IS model. Histological analysis was performed using Nissl staining. Neuronal loss was detected using TUNEL staining. OGD/R was used to establish in vitro cerebral I/R injury model. Gene expression was detected using RT-qPCR and Western blot. Cytokine release was detected using ELISA. Cellular functions were detected using CCK-8 assay, LDH assay, flow cytometry, and TUNEL staining. GSDMD transcription was detected using luciferase and ChIP assays.
Results
CHR alleviated OGD/R induced neuronal damage, as well as inhibited oxidative stress, inflammatory response, and neuronal pyroptosis in vivo and in vitro. CHR promoted the activation of NRF2/ARE signaling. NRF2 inhibited the transcription of GSDMD, resulting in its downregulation. However, inhibition of NRF2 signaling contributed to neuronal damage and pyroptosis.
Conclusions
CHR protects against cerebral I/R injury-induced neuronal loss by regulating NRF2/ARE/GSDMD signaling pathway. Therefore, CHR may be a promising strategy for cerebral I/R injury.
期刊介绍:
Tissue and Cell is devoted to original research on the organization of cells, subcellular and extracellular components at all levels, including the grouping and interrelations of cells in tissues and organs. The journal encourages submission of ultrastructural studies that provide novel insights into structure, function and physiology of cells and tissues, in health and disease. Bioengineering and stem cells studies focused on the description of morphological and/or histological data are also welcomed.
Studies investigating the effect of compounds and/or substances on structure of cells and tissues are generally outside the scope of this journal. For consideration, studies should contain a clear rationale on the use of (a) given substance(s), have a compelling morphological and structural focus and present novel incremental findings from previous literature.